Arbutus Biopharma
ABUS
4.29
-0.19
-4.24%
Arbutus Biopharma
US · ABUS
#3365 by market cap
Listed 2015
4.29
-0.19
-4.24%
Live - 5344 symbols - heartbeat 23s ago
· 2026-10-08 08:32
Pre-market
4.35
+1.31%
After-hours
4.30
+0.23%
- Market cap
- 849.87M
- P/E (TTM)i
- 5.43
- P/Bi
- 3.28
- EPSi
- -0.17
- Div yieldi
- 0.00%
- 52W posi
- 41%
Reader sentiment
Are you bullish or bearish on ABUS?
Anonymous reader poll. Unscientific, not investment advice.
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2024/Q3 | 2024-11-06 | -- | ±13.36% | -1.01% (in line) |
| 2024/Q2 | 2024-08-01 | -- | ±16.39% | +1.06% (in line) |
| 2024/Q1 | 2024-05-02 | -- | ±14.39% | -0.37% (in line) |
| 2023/Q4 | 2024-02-29 | -- | ±24.31% | -2.78% (in line) |
| 2023/Q3 | 2023-11-07 | -- | ±15.96% | -1.60% (in line) |
| 2023/Q2 | 2023-08-03 | -- | ±12.02% | -0.96% (in line) |
| 2023/Q1 | 2023-05-04 | -- | ±23.90% | +1.59% (in line) |
| 2022/Q4 | 2023-03-02 | -- | ±33.56% | +0.00% (in line) |
| 2022/Q3 | 2022-11-09 | -- | ±30.24% | -0.81% (in line) |
| 2022/Q2 | 2022-08-04 | -- | ±19.31% | +3.25% (in line) |
| 2022/Q1 | 2022-05-05 | -- | ±17.95% | +2.41% (in line) |
| 2021/Q4 | 2022-03-03 | -- | ±24.11% | -4.53% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Recent analyst ratings 1
| Date | Firm | Rating | Target |
|---|---|---|---|
| 2025-12-11 | Jefferies | BUY | 7.00 |
Quote time 2026-10-08 08:32:55 · For reference only, not investment advice and not tailored to your situation.